Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind Placebo-controlled Exploratory Trial to Assess the Impact of Daily Lab4P Probiotic Supplementation on Cognitive Performance and Metabolic Regulation in Overweight Young Adults With Impaired Glucose Regulation

NCT07073781 is registered in ClinicalTrials.gov with Leeds Beckett University as lead sponsor.

NCT NCT07073781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07073781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind Placebo-controlled Exploratory Trial to Assess the Impact of Daily Lab4P Probiotic Supplementation on Cognitive Performance and Metabolic Regulation in Overweight Young Adults With Impaired Glucose Regulation
Lead sponsor
Leeds Beckett University
Phase
Not applicable
Overall status
Recruiting
Start date
August 15, 2025
Completion date
August 20, 2027
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive dysfunction, impaired glucose regulation, impaired glucose tolerance (prediabetes), neurovascular coupling mechanism and cognitive function, overweight (bmi > 25), prediabetes (insulin resistance, impaired glucose tolerance)